For instance, inactivation of EST, the enzyme responsible for oestrogen deactivation, increases energy expenditure, improves insulin sensitivity, and reduces hepatic gluconeogenesis and lipogenesis in different mouse models of obesity-related metabolic disorders, but only in females [57]. This evidence concerns the gene INS and metabolic disease.